NewsRoom Articles - Page 180 of 227

TuesdayApr 13, 2021 1:31 pm

Real-World Evidence and Market Access Symposium Features Timely Advisement During COVID Era

Organized by Dynamic Global Events (“DGE”), a market research and event outreach organization with experience in relevant B2B life science conferences Taking place April 14-15 with an online, live-streamed format Experts from some two dozen organizations and companies addressing timely real-world evidence (“RWE”) applicable to the COVID-19 pandemic’s disruptive effect on societies A potential tool for preparing to transform regulatory submissions, clinical decision making and value demonstrations Dynamic Global Events (“DGE”) will leverage its extensive market research, targeted outreach and content-driven team’s experience to deliver the latest in a series of relevant B2B events within the life sciences arena, focusing…

MondayApr 12, 2021 3:01 pm

Nonhospitalized Long-Haul Coronavirus Patients Susceptible to Cognitive Dysfunction

A group of researchers from the Feinberg School of Medicine at Northwestern University has discovered additional evidence of cognitive dysfunction in many coronavirus patients who were not hospitalized after contracting the infection. The group’s findings were reported in the “Annals of Clinical and Translational Neurology” journal. In the study, the researchers looked into medical data of nonhospitalized coronavirus patients from 21 different states who were experiencing long-term symptoms of the coronavirus, documenting what they discovered from the study. As the pandemic surges on, despite measures to contain it, media outlets have continued to report statistics on the number of mortalities…

MondayApr 12, 2021 1:01 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Files First Order for Rapid COVID Test Kits Amid European Regulatory Approval

Bioscience technology accelerator XPhyto Therapeutics Corp. recently announced it had placed its first order for its Covid-ID Lab rapid, portable virus test from its German development partner XPhyto received approval for the test kit last month from European regulators with oversight of in vitro diagnostic device (CE-IVD) use certification and the internationally agreed-on ISO 13485 medical product quality standards The Covid-ID Lab is designed to help beleaguered industries and government regulators quickly screen for the COVID-19 virus at point-of-care sites, and the company expects to begin sales and distribution in April XPhyto has just completed a rebranding effort that includes…

MondayApr 12, 2021 12:30 pm

Brain Scientific Inc. (BRSF) Changing the Landscape by Tackling Neurology Deserts

Distribution of neurologists across the U.S. is uneven with 20 states experiencing neurology deserts Brain Scientific has developed tools that help providers in neurology deserts provide access to neurological care With explosion of telemedicine services and increased integration of advanced practice providers, neurologists' shortage may improve Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company, is directly tackling the shortage of neurologists in the United States with cutting-edge technologies. By creating cost-efficient, disposable and portable EEGs, BRSF makes neurology care more accessible without putting excess strain on the already overextended neurologist labor pool. Between 2001 and 2016, the American Academy of…

FridayApr 09, 2021 2:39 pm

Research Discovers Vaccinating Women Against COVID-19 Passes Antibodies to Unborn Babies

Researchers from Harvard, MIT, the Ragon Institute of MGH, Brigham and Women’s Hospital and Massachusetts General Hospital recently conducted a study that discovered that the new mRNA coronavirus vaccines were highly efficacious in producing antibodies against the SARS-CoV-2 virus in lactating and pregnant women. The researchers also showed that the vaccines offered protective immunity to newborns through the placenta and breast milk. Their findings were reported in the “American Journal of Obstetrics and Gynecology” and observed 131 women, 16 of whom weren’t pregnant, 31 who were lactating and 84 who were pregnant, all of reproductive age. All the study participants…

FridayApr 09, 2021 2:26 pm

RYAH Group Inc. Offers IoT Suite of Products Disrupting Future of Medicine

Every product features three parts: dosing device, formulation accessory and mobile app HIPPA-compliant cloud collects data along each step that is essential in tailoring personalized treatment plan RYAH offers multi-product ecosystem that provides remote-health solutions in patient treatment RYAH Group a digital health-care analytics and technology company, has developed an ecosystem of IoT products in its mission to advance the world's transition to remote-health solutions and data analytics in patient treatments (https://ibn.fm/1wvz4). Every product features three parts: the device, the formulation accessory (QR labeled product) and the mobile application. These parts work together to control the dosing while also capturing important…

ThursdayApr 08, 2021 2:30 pm

Researchers Find That Dining Out Frequently Increases Risk of Mortality

Researchers from the University of Iowa recently examined the link between the risk of death and dining out and came to the conclusion that eating out too often was linked to an increased risk of all-cause death. The findings were reported in the “Journal of the Academy of Nutrition and Dietetics.” Eating out is a popular activity globally, and while not much research has been done into its link with health outcomes, the conclusion warrants further study on the matter. The U.S. Department of Agriculture estimates that the daily energy intake from food away from home for Americans had increased…

ThursdayApr 08, 2021 2:24 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Commercialization Team Set to Launch Rapid POC COVID Test Solution

Bioscience technology accelerator XPhyto Therapeutics Corp. is working with development partner 3a-diagnostics GmbH to roll out its pandemic-related virus diagnostic tool for the European market planned in April The test solution, dubbed “Covid-ID Lab,” received European regulatory approval last month XPhyto’s product is designed to be portable and rapid in its response time to help decrease testing operation costs and increase convenience of use News reports about the COVID-19 pandemic reflect a growing optimism that vaccine, mask and distancing protocols may be helping to drive down infection rates, although the reports note the virus continues to have a deadly effect…

ThursdayApr 08, 2021 1:08 pm

Brain Scientific Inc. (BRSF) Meeting the Needs of Neuro Research

BRSF is creating mobile, easy-to-use electroencephalogram (“EEG”) devices that enhance research integrity There is an increasing desire to understand the brain’s capabilities and harness them for healing Brain Scientific provides a cost-efficient, pre-gelled, disposable and wireless solution that provides the same signal quality as the traditional wired EEG A growing consumer market for brain-computer interface (“BCI”) technology has some researchers worried about the quality of the data being collected. Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has developed wireless, portable, easy-to-use electroencephalogram (“EEG”) devices that do not compromise research integrity. Data collected from consumer-centric, low-cost BCIs…

WednesdayApr 07, 2021 2:43 pm

Patients with Incurable Brain Cancers Find New Hope in University Study, Upcoming CNS Pharmaceuticals (NASDAQ: CNSP) Clinical Trial

Glioblastoma Multiforme (often known simply as GBM) is a fatal, incurable class of brain cancers that usually leaves patients only about 15 months to live once they are diagnosed A recent study by the Washington University School of Medicine found that the length of survivability appeared to improve when the standard chemotherapy regimen was given in the morning instead of the evening Brain cancer drug developer CNS Pharmaceuticals is also working on a solution to improve the quality of GBM care, seeing hope in its lead drug candidate, Berubicin, which showed promise in a small Phase 1 trial nearly 15…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Real-World Evidence and Market Access Symposium Features Timely Advisement During COVID Era

Nonhospitalized Long-Haul Coronavirus Patients Susceptible to Cognitive Dysfunction

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Files First Order for Rapid COVID Test Kits Amid European Regulatory Approval

Brain Scientific Inc. (BRSF) Changing the Landscape by Tackling Neurology Deserts

Research Discovers Vaccinating Women Against COVID-19 Passes Antibodies to Unborn Babies

RYAH Group Inc. Offers IoT Suite of Products Disrupting Future of Medicine

Researchers Find That Dining Out Frequently Increases Risk of Mortality

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Commercialization Team Set to Launch Rapid POC COVID Test Solution

Brain Scientific Inc. (BRSF) Meeting the Needs of Neuro Research

Patients with Incurable Brain Cancers Find New Hope in University Study, Upcoming CNS Pharmaceuticals (NASDAQ: CNSP) Clinical Trial

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search